The terms “star ratings” and “performance measures” are often incorrectly used interchangeably. Here’s a look at what each means and how it applies to pharmacies.
The Senate Finance Committee passed a new legislation that would require increased transparency from PBMs, and more news to know.
As the most accessible healthcare providers, pharmacists have a prime opportunity to have meaningful and honest dialogue with patients. Adopting motivational interview techniques to improve communication with patients can help them address patient ambivalence and non-adherence.
Pillpack pushes back against Surescripts for blocking its access to patient health data, and more news to know.
Advancements in technology are changing the way healthcare providers treat and communicate with patients in unprecedented ways. Here are three trends worth noting as they make their mark on the healthcare industry.
The Trump Administration scraps plan to ban rebates on drugs in Medicare Part D, and more news to know.
Despite what many expect, high-performing pharmacies often still have to deal with DIR fees. Here’s why.
Amid a shortage of EpiPens, Novartis is extending the availability of its generic pre-filled epinephrine shots to pharmacies across the U.S., and more news to know.
Earlier this year, CMS released updates to Medicare Advantage and Part D programs for the upcoming plan year. As we look ahead to Open Enrollment, here’s a breakdown of some of the major changes.
A bipartisan bill could help provide shingles and Tdap vaccinations to Medicare beneficiaries at no extra cost, and more news to know.